Sort by
Refine Your Search
-
, there are several exciting opportunities for a variety of very interesting projects beyond structure-function studies of cytoskeletal proteins that control signaling downstream of adherens junctions and focal
-
additional AD risk genes and to develop disease models. Work on the projects studying molecular mechanisms that recently identified Alzheimer’s disease risk repeat expansion variants contribute to disease
-
protostellar evolution models to radiative transfer grids. The goal is to synthesize these protostar models into protocluster models and compare them to JWST and ALMA data. The applicant must have a Ph.D. in
-
comprehensive land grant university with an enrollment of over 50,000 students and was ranked 6th in the country among public universities (US News and World Report 2023 rankings), and 1st among public
-
development in Drosophila and beyond. We are an evolutionary and developmental genetics lab, broadly interested in the structure and evolution of the gene circuits that underlie organ development and function
-
strains, using synthetic biology approaches to detect, report, and treat colorectal cancer (CRC) and other diseases. Engineered strains will be evaluated in cell-based, organoid, and animal disease models
-
/ https://www.evansresearchgroup.org/ ) in the Department of Chemistry We have a position available in our groups to work on exploiting polymer topology to advance next-generation energy storage systems
-
Association of American Universities (AAU), the University of Florida is the state’s oldest and most comprehensive land-, sea-, and space-grant university, with an enrollment of over 50,000 students. In 2025
-
)-statistics, (applied) mathematics, or a related STEM field. Prior working experience with EHR data, machine learning, NLP, bioinformatics, and large language models (LLM) is preferred. In particular
-
structural elucidation, and (iii) synthetic chemistry and biocatalysis for the preparation and evaluation of antibody-drug conjugates (ADCs) as the next generation anticancer therapies by site-specific